Susquehanna Fundamental Investments, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$13.05 - $22.13 $207,508 - $351,889
-15,901 Reduced 57.11%
11,940 $177,000
Q1 2022

May 16, 2022
SELL
$17.64 - $39.57 $93,492 - $209,721
-5,300 Reduced 15.99%
27,841 $751,000
Q4 2021

Feb 14, 2022
BUY
$34.2 - $47.56 $548,568 - $762,862
16,040 Added 93.8%
33,141 $1.23 Million
Q2 2021

Aug 11, 2021
BUY
$25.79 - $42.11 $441,034 - $720,123
17,101 New
17,101 $579,000

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $450M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email